Meet our Leaders

Shane Cooke

President & Chief Executive Officer

Shane Cooke joined Etiometry in 2019 as President & CEO, bringing over 20 years of experience in the medical device and pharmaceutical market spaces in a variety of sales, marketing, strategy and portfolio management roles.

Before joining Etiometry, Shane spent 5+ years as Chief Strategy Officer of Cheetah Medical, which was acquired by Baxter International in 2019. Prior to Cheetah, Shane spent 11 years with Covidien in the patient care, vascular therapies and corporate sectors, with positions such as: corporate strategy, market and competitive intelligence, leading the market development center of excellence and leading strategy efforts for Japan, Europe, Australia and Canada. Shane holds a BA in psychology from the University of Rochester, as well as an MBA from Suffolk University.

Evan Butler

Chief Operating Officer

Evan Butler is an engineer and entrepreneur who co-founded Etiometry in 2010. Previously, he worked at Boston Children’s Hospital in the Pediatric Cardiac Bioengineering Laboratory designing, building and testing novel surgical robots and tools. Evan was also a NASA GSRP Fellow with Dryden Flight Research Center, and created intelligent flight control systems.
He received his Bachelor’s degree in Physics and Aerospace Engineering, and his Masters degree in Dynamics and Control Engineering from Boston University. Evan has published conference papers, journal articles and a book chapter in the fields of medical predictive analytics, concentric tube robots and tools for minimally-invasive beating heart surgery, and intelligent flight control systems. Evan has received multiple awards, including the 2010 IEEE Transactions on Robotics Best Paper Award.

Dimitar Baronov, PhD

Chief Technology Officer

Dimitar Baronov is a co-founder of Etiometry and leads the company’s research and development organization. He received his Bachelor’s degree from Technical University in Sofia, Bulgaria and a Ph.D. in Aerospace Engineering from Boston University. Before co-founding Etiometry, Dimitar developed a theory for optimal human-machine interaction in achieving complex tasks.

This work informed the U.S. Air Force, and provides a basis for Etiometry’s innovative approach to integrating analytics into medical care. As CTO of Etiometry, Dimitar is the lead designer of the Etiometry Platform that quantifies clinical risks based on continuous streams of physiologic data. He has also served as the Principal Investigator for several National Institute of Health grants.

Zeke Oakley

Vice President of Engineering

Zeke Oakley has over a decade of experience working with real-time data acquisition and processing systems. He received his Master’s Degree in Dynamics and Control Engineering from Boston University, where he focused on real-time communication within distributed sensor networks. He began his career working at Martinos Center for Biomedical Imaging where he developed streamlined MEG and EEG data processing workflows and interactive experimental procedures.

At Etiometry, he has worked as a Principal Systems Engineer, responsible for architecting and implementing many of the company’s core technologies. Zeke brings a fundamental understanding of Etiometry’s products and services, and a strong inter-disciplinary background to the company’s software design and development processes.

Jeff Gaus

Vice President of Sales

Jeff Gaus has spent the past 22-plus years in sales and sales leadership roles with Johnson & Johnson, Kyphon/Medtronic, Cardiovascular Systems, Inc and most recently with Cheetah Medical, an early-stage company acquired by Baxter International in 2019. He has spent his entire career representing and promoting ground-breaking technologies focused on improving clinical outcomes in the urology, spine, cardiovascular and critical care arenas. Prior to entering the medical device space, Jeff was an aeromedical evacuation officer in the US Army for 7 years. Jeff holds a Bachelor of Arts degree in Biology/Sportsmedicine from Canisius College.

Howard Brick

Chief Strategy Officer

Howard Brick joined Etiometry in 2021 as Chief Strategy Officer, bringing over 20 years of experience in healthcare technology-related information and analytics companies in a variety of executive, commercial, and corporate development roles.

Before joining Etiometry, Howard consulted to and advised medical technology and digital health companies on strategic partnering, financing, and go-to market strategies.  Prior roles included SVP of Business Development for Senscio Systems, Managing Director at Ferghana Partners and Managing Director, COO and then CEO of MedPanel, a market intelligence provider to the life sciences industry and to life sciences-focused investors.

Prior to his career in the healthcare vertical, he worked in mortgage banking analytics and practiced law in Boston.  Howard holds a B.A. from Dartmouth College and a J.D. from Columbia University Law School.